Name of Clinical Trial: A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer / NCT06557148 Eligible patients: Patients with estrogen receptor positive […]
A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer Read More »
Name of Trial/NCT#: Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers / NCT05919108 Eligible patients: Individuals over 18 years of age newly diagnosed with
Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers Read More »
Name of Trial: Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)/NCT05964504 Eligible patients: Patients with histologically confirmed metastatic (stage IV) lobular breast cancer, regardless
PLUMB Registry: Improving Survival for Metastatic Lobular Breast Cancer Read More »
Name of Trial: REPLOT: A Phase II Study of REPotrectinib With or Without Fulvestrant in Patients With Hormone Receptor-positive Human Epidermal Growth Factor 2-negative Metastatic
REPLOT: Clinical Trial for Patients with Metastatic ILC Read More »
"*" indicates required fields
